stars 1 stars 2 stars 3

Transcriptome Sciences Inc. (TSI), a privately held Alberta research company incorporated in 2008, is the commercial spin-off of the Alberta Transplant Applied Genomics Centre (ATAGC) at the University of Alberta in Edmonton, Canada. Transcriptome (TSI) is dedicated to developing a new understanding of disease mechanisms through the molecular analysis of transplanted organ biopsies, and to the commercialization of these discoveries. The result is an extensive and growing proprietary database consisting of clinical, histological, and gene expression findings from these biopsies, supplemented with patient outcomes. Transcriptome’s (TSI) database forms the basis of the Molecular Microscope® Diagnostic (MMDx®) system, a novel central diagnostic process for the assessment of organ disease states with unparalleled accuracy.

Transcriptome Sciences Inc. Questions

The Transcriptome Sciences Inc. annual revenue was $4 million in 2026.

Phil Halloran is the CEO of Transcriptome Sciences Inc..

5 people are employed at Transcriptome Sciences Inc..

Transcriptome Sciences Inc. is based in Edmonton, Alberta.

The NAICS codes for Transcriptome Sciences Inc. are [5417, 54171, 54, 541713, 541].

The SIC codes for Transcriptome Sciences Inc. are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users